|
HS Code |
338167 |
| Generic Name | Ornidazole |
| Drug Class | Nitroimidazole antimicrobial |
| Chemical Formula | C7H10ClN3O3 |
| Molecular Weight | 219.63 g/mol |
| Dosage Forms | Tablets, Infusion, Suspension |
| Mechanism Of Action | Inhibits DNA synthesis in microorganisms |
| Primary Indication | Treatment of protozoal infections |
| Route Of Administration | Oral, Intravenous |
| Half Life | 12-14 hours |
| Metabolism | Hepatic |
| Excretion | Renal and fecal |
| Appearance | White to pale yellow crystalline powder |
As an accredited Ornidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ornidazole packaging: White box with blue accents, labeled "Ornidazole Tablets 500 mg," contains 10 tablets in a blister strip. |
| Shipping | Ornidazole is shipped in tightly sealed, clearly labeled containers to prevent contamination and ensure safety. The packaging complies with local and international regulations for transporting chemicals. It should be stored and transported in a cool, dry place, away from direct sunlight and incompatible substances. Handle with care to avoid breakage or spillage. |
| Storage | Ornidazole should be stored in a tightly closed container at room temperature (15–30°C), protected from light and moisture. Keep it away from heat, direct sunlight, and incompatible substances. Store in a dry, well-ventilated area, and ensure it is out of reach of children and pets. Follow local regulations regarding chemical storage and disposal for safety. |
|
Purity 99%: Ornidazole with a purity of 99% is used in anaerobic bacterial infection treatments, where it ensures rapid pathogen eradication and minimizes resistance development. Molecular Weight 219.64 g/mol: Ornidazole (molecular weight 219.64 g/mol) is used in oral suspension formulations, where it facilitates accurate dosing and consistent therapeutic levels. Melting Point 85-87°C: Ornidazole with a melting point of 85-87°C is used in tablet manufacturing processes, where it improves thermal stability and uniform drug dispersion. Particle Size <50 μm: Ornidazole with a particle size less than 50 μm is used in intravenous infusions, where enhanced solubility and accelerated drug release are achieved. Stability Temperature Up to 40°C: Ornidazole with stability up to 40°C is used in tropical region packaging, where it maintains shelf-life and pharmacological activity under higher ambient temperatures. Water Solubility 7 mg/mL: Ornidazole with water solubility of 7 mg/mL is used in pediatric syrup formulations, where it ensures facile mixing and optimal bioavailability. Loss on Drying ≤0.5%: Ornidazole with a maximum loss on drying of 0.5% is used in granule blending, where it guarantees moisture control and prevents caking during production. Residual Solvents <0.1%: Ornidazole with residual solvents below 0.1% is used in parenteral drug products, where it meets stringent safety standards and minimizes patient toxicity risks. |
Competitive Ornidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ornidazole brings a practical solution for those dealing with infections caused by anaerobic bacteria and protozoa. This compound, part of the nitroimidazole family, finds its way into clinics and hospitals worldwide. Unlike standard antibiotics that often struggle against specific single-cell organisms, Ornidazole breaks through the defenses of amoebas, Giardia, and Trichomonas species. That ability makes it an important choice when physical discomfort and disruption from these parasites affect daily routine. In communities where access to clean water and sanitation sometimes falls short, the value of a drug that can swiftly tackle protozoal illness goes beyond individual relief—it brings families peace of mind.
Early in my career, I saw firsthand how people living in rural areas—places where support isn’t always just a quick drive away—relied on dependable medicines to recover from stubborn stomach upsets caused by organisms that most folks simply don’t think about. Ornidazole won the trust of both doctors and patients with consistent results in managing upset stomach and infections that didn’t budge with other antibiotics.
Most patients and prescribers gravitate toward oral tablet and suspension forms, as they promise ease of use and straightforward dosing. Adults typically receive tablets, usually 500mg or 1000mg strengths—sizes that balance the need for swift action without going overboard. Children or patients who struggle swallowing pills find suspensions easier and more reliable. Several trusted generic versions show up on pharmacy shelves, all focused on accurate dosing, consistent breakdown in the gut, and long shelf life.
Ornidazole’s stability under typical storage conditions means families in hot climates—where refrigerators sometimes fail during power cuts—can still trust that the tablets remain effective. A product that doesn’t melt or lose power in the heat can mean the difference between relief and days of avoidable misery.
Ornidazole treats real illnesses, not rare oddities. People use it for gut upsets from amoebiasis, persistent diarrheas linked to Giardia, and a range of infections in the reproductive system. Doctors also rely on it off-label for mixed bacterial infections, particularly in dental and gynecological clinics where anaerobes make simple problems complicated.
Ornidazole stands out not because it tackles every germ, but because it zeroes in on organisms that love low-oxygen pockets in the body. I’ve seen dentists prescribe it after tough tooth extractions, aiming to head off infections hiding behind swollen gums. Gynecologists often turn to Ornidazole to relieve women whose daily work and family obligations simply don’t pause for a stubborn infection. Outpatient clinics—especially in parts of the world with tough tropical climates—work with Ornidazole for its consistent track record.
The typical course lasts just a few days, reducing the risk of people forgetting later doses or dropping treatment halfway through. Because of this short commitment, Ornidazole helps busy parents and caregivers follow through, even when life gets complicated.
Some folks ask why not just use metronidazole, a better-known cousin. Ornidazole’s advantage comes down to staying power and gentler hands. The longer half-life means you swallow fewer pills over the course of treatment. It helps patients stick to instructions, which doctors know is half the battle in beating an infection. Some people experience fewer headache and stomach complaints with Ornidazole. That’s not always true for every patient, but in groups where side effects from related drugs cause more trouble than the illness itself, Ornidazole can offer relief without the price of missed work or lost sleep.
Another key factor shines through in patient stories. In settings where people deal with multiple health issues—diabetes, high blood pressure, chronic pain—minimizing extra medication burden matters. Ornidazole’s dosing schedule lightens the load, giving people less to keep track of at busy times of day. Elderly users and those caring for more than one family member especially notice the difference. For doctors, the choice between two drugs often rests on subtle distinctions: ease of administration, pace of recovery, and the ability to complete a course of treatment with minimal extra fuss. Ornidazole carves out a space in these scenarios, aiming for useful outcomes with manageable inconvenience.
The question of safety always hovers in the background. Ornidazole doesn’t escape scrutiny, nor should it. Solid studies over decades provide reassurance. Most users tolerate it well, reporting headache, tiredness, or occasional nausea far less frequently than with older alternatives. In populations already under stress from chronic conditions, Ornidazole appears to fit in without serious interactions.
Countries with strict drug oversight, such as those in the European Union and Asia, have reviewed and updated guidelines for years. Doctors look for signs of rare but serious issues—such as nerve changes or allergic responses—and know to warn patients. The odds of lasting harm stay low when people use Ornidazole as instructed, for the right diagnoses, at approved doses. Importantly, the medical community continuously reviews reports and updates access, ensuring Ornidazole doesn’t just coast on reputation but proves itself in ongoing observation.
Modern life doesn’t always guarantee perfect hygiene or flawless infrastructure. In many regions, clean water still can’t be taken for granted. The result is a heavy burden of intestinal infections. Ornidazole shows its worth most clearly in these overlooked communities. In clinics where laboratory equipment lags behind, and where diagnosis by symptoms counts for more than technical tests, the proven impact of a well-chosen medication becomes obvious. Health workers see children and adults return to energy, appetite, and good spirits after just a short course.
My own observations match findings from public health research: access to a dependable anti-infective can raise the baseline of community well-being. Children miss fewer days of school, adults lose fewer hours of productive work, and the whole system gains resilience. Ornidazole doesn’t fix crumbling infrastructure or solve underlying water quality crises, but it does give hard-working families a real lifeline.
All too often, antimicrobial drugs become overused or used in the wrong context. Early success sometimes tempts clinics and patients to turn to Ornidazole for complaints it won’t solve—like viral infections or simple aches. This urge can weaken the tool in the long run, as organisms develop resistance and treatment failure becomes more likely.
Preventing resistance takes more than regulation and paperwork. It starts with doctors and pharmacists who educate patients about the limits of these medications. Community leaders, too, can play a role, clearing up harmful myths and making sure people seek medical input for symptoms that seem to repeat or linger longer than a few days.
In some areas, government programs focus on training primary care workers, not just in how to give Ornidazole, but in how to explain its right uses. Peer-to-peer education works—local healthcare workers who live in the community show others, in plain language, which symptoms matter and which don’t, cutting back on unnecessary use. For countries dealing with rising resistance rates, these efforts anchor responsible prescribing.
Long shelf-life and simple storage requirements mean Ornidazole stands apart in places without secure supply chains. Other drugs break down in humidity or lose power on the shelf after a few months, but Ornidazole’s durability keeps it ready. For people moving between rural areas and city jobs or traveling between regions, counting on medication to work after weeks in a warm bag or poorly ventilated cabinet gives rare peace of mind.
Generics make Ornidazole affordable and widely available. After years of brand-name production, off-patent versions lower costs, stretching the same health budget across more families. In less affluent regions, this pandemic-era lesson holds strong: medicine that’s too expensive or too delicate for everyday life doesn’t actually help anyone. Ornidazole keeps costs realistic, resting among the few drugs that bridge the gap between advanced medical science and daily reality in small towns and city neighborhoods alike.
A key lesson from my experience comes from home visits. Seeing patients use Ornidazole as prescribed, with thoughtful instruction, often stops infection spirals early—avoiding repeat doctor trips, lost wages, and the spread of illness to others. The chain of benefit runs outward, reducing local outbreaks and even making minor surgery and childbirth safer by lowering background infection rates.
Increasingly, the conversation about anti-infective therapy includes access and training, not just purchase and dosage. Health workers in under-resourced settings ask for not just medicine, but guidance—clear illustrations, locally relevant dosing charts, and translation into widely spoken languages. People who understand what an antibiotic treats, along with symptoms to watch for, become safer users and more responsible family caregivers.
Some public health efforts now prioritize community engagement: local radio programs, hands-on workshops, family meetings that include practical skills such as spotting dehydration and knowing which symptoms mean a trip to the clinic. Ornidazole lends itself to these conversations due to its familiar place in local practice and recognizable packaging.
Better data gathering on illnesses—and smarter drug distribution—could help target Ornidazole where it’s most useful, instead of blanketing populations blindly. Pharmacies and clinics that track real-time patterns of gut and reproductive infections can work with regional suppliers, avoiding both stockouts and wasteful oversupply.
Empowering patients by providing basic health literacy—how and when to complete a course, reporting side effects, recognizing signs of deeper infection—makes Ornidazole a bridge to broader health improvement. This approach respects people’s intelligence and resourcefulness, letting the medicine work as designed, not wasted or sabotaged by confusion or misinformation.
Some voices argue that self-medication hurts public health. Others recognize that in places where doctors are scarce and hospital beds fill quickly, informed self-care can do much good. Ornidazole straddles the line, trusted both in clinics and in home cupboards. In family medicine, experienced mothers, grandparents, and caretakers learn to recognize the flare-up of familiar symptoms—those same sharp stomach pains, feverish shivers, or bouts of diarrhea. Properly supported by earlier clinic visits and clear advice, these caregivers can give Ornidazole safely, stepping in early and forestalling complications.
The challenge? Ensuring the right information travels with every bottle. Clear labeling, graphic instructions, and locally tailored guidance matter. Community health workers, pharmacists, and even school teachers can form a team, sending sound advice home with students and patients alike. Ornidazole works best as part of this locally grounded network, not in isolation or in the shadow of “one-size-fits-all” advice.
Medical science evolves quickly, yet trusted options like Ornidazole continue to earn their place through solid research. Academic and pharmaceutical groups still look for ways to improve the experience—maybe in taste, reduced stomach upset, or simpler dosing for children. Partnerships between clinicians and lab scientists sometimes uncover new uses, such as tackling treatment-resistant strains of old foes. It’s not unusual for an old drug to find new roles, given determination and close patient monitoring.
Public-private partnerships and non-profit research organizations can foster better understanding of how Ornidazole works in emerging disease patterns, particularly as climate change, urbanization, and migration shift the map of infectious disease. Keeping doctors and local clinics in conversation with researchers gives real-time feedback, driving both innovation and practical adaptation.
Health delivery faces sharp divides—between rural and urban, high-resource and low-resource, high education and low literacy. Ornidazole threads through these divides, showing up everywhere due to its balance of cost, resilience, and versatility. Governments that emphasize robust supply chains, clear educational materials, and local involvement deliver the best experience. Health professionals continuously compare outcomes, track new trends, and—most valuably—share knowledge across borders and disciplines.
For multinational health systems, careful regulation keeps Ornidazole reliable. Local generics compete on quality and price, spurred by regular government audits and consumer watchdogs. Pharmacists serve as critical gatekeepers, counseling patients on proper use, warning about interactions, and reinforcing the importance of completing the course. In clinics serving homeless populations, migrant workers, or transient rural laborers, Ornidazole often surfaces as the link between stable care and the reality of a life spent on the move.
Family medicine now looks beyond single prescriptions, considering how one drug fits into the circle of ongoing care. Nurses, too, play a role, often as the most accessible face of healthcare. In outpatient settings, nurses recognize early warning signs of treatment failure and see patterns that haven’t yet reached larger databases. Their feedback shapes how Ornidazole—and other anti-infectives—get used, shifted, or rotated in community protocols.
Combating misuse and resistance doesn’t mean restricting access. More effective solutions center on making guidance clear and keeping follow-up support available to those using Ornidazole at home. Telemedicine now bridges some gaps, letting patients report progress or ask questions quickly, without sacrifices in privacy or travel expenses. Simpler refill protocols, robust pharmacy records, and careful feedback loops increase the likelihood of treatments completed fully and correctly.
On a bigger scale, international agencies support governments and communities to keep essential medications available and safe from counterfeiting or degradation. Bulk purchasing agreements and regular review of procurement ensure that families don’t face outlandish prices or expired doses. Spot-check research—real-world audits of drug quality—keeps manufacturers accountable, with doctors and nurses fielding firsthand reports in clinics serving diverse populations.
The biggest impact often comes from tiny shifts: a single well-informed caregiver, a teacher who spots a sick student and connects with the clinic, a pharmacist who takes an extra moment to answer questions. Ornidazole exists within this web of support, contributing not by magic, but by solid, grounded utility.
Trust in medication never happens overnight. It grows—dose by dose, family by family—across years. Ornidazole earns that trust by delivering what it promises and adjusting as new challenges arise. Doctors, nurses, and community leaders all play a part, guided by evidence and the lived experience of families battling tough infections. For those living in uncertain or challenging circumstances, Ornidazole can offer predictability and hope—a small but significant tool in the ongoing fight to safeguard everyday health.